Gut microbes revealed as key players in liver disease solutions

In the editorial published on 4 September 2023, in the “gut-liver axis” special issue of the journal Hepatobiliary & Pancreatic Diseases International, Dr. Jian-Gao Fan and Dr. Lu Jiang from Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine provided a comprehensive elucidation of the pivotal role of gut microbiota in various liver diseases.

Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications | Psychedelic Invest

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals

September 14, 2023

Platform Trial Looks at Endometrial Cancer Treatment Combinations

A phase II study is investigating olaparib (Lynparza), cediranib (Recentin), durvalumab (Imfinzi), or investigational capivasertib in various treatment combinations in patients with recurrent, persistent, or

July 11, 2023

Combined marijuana and cigarette smoking may increase lung damage

Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs, according to research being presented today at the annual

November 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.